Dianthus Therapeutics (DNTH) market cap

Market cap today
$4.90B

Dianthus Therapeutics (DNTH) has a market cap of $4.90B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.59B. That is 119.1% higher than the $726.24M of fiscal 2024. Today's figure is 207.8% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 04:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$4.90B
Market cap, fiscal 2025
$1.59B
Change on fiscal 2024
+119.1%
Highest on record
$1.59Bfiscal 2025
Lowest on record
$53.60Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Dianthus Therapeutics market cap, in more detail

Across the 4 fiscal year-ends on record (2022–2025), the highest was $1.59B in fiscal 2025 and the lowest $53.60M in fiscal 2023.

History · 4 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Dianthus Therapeutics market cap, year by year

Dianthus Therapeutics (DNTH) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$4.90B—$86.98—
2025$1.59B 119.1% up$41.2138.62M
2024$726.24M 1,255.0% up$21.8033.31M
2023$53.60M 43.5% down$10.405.15M
2022$94.83M—$6.4014.82M
2021——$70.88—
2020——$125.44—
2019——$242.56—
2018——$91.20—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Dianthus Therapeutics and comparable companies
CompanyMarket cap
LivaNova LIVN$5.06B
Ionis Pharmaceuticals IONS$4.49B
Dianthus Therapeutics DNTH$4.90B
MiniMed Group MMED$5.00B
Adaptive Biotechnologies ADPT$4.61B
Heartflow HTFL$4.14B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics market cap: questions and answers

What is Dianthus Therapeutics's market cap?

Dianthus Therapeutics (DNTH) has a market cap of $4.90B. At the end of fiscal 2025 (December 31, 2025) its market cap was $1.59B. That is 119.1% higher than the $726.24M of fiscal 2024.

What are the highest and lowest market cap figures on record for Dianthus Therapeutics?

Across the 4 fiscal year-ends on record (2022–2025), the highest was $1.59B in fiscal 2025 and the lowest $53.60M in fiscal 2023.

How is Dianthus Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/DNTH/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.